Dermatology Search
Dermatology Dermatology
atopic%20dermatitis
ATOPIC DERMATITIS
Atopic dermatitis or atopic eczema is a chronic, relapsing, familial, symmetric and pruritic inflammatory skin disease that commonly presents during early infancy and childhood, but can persist or start in adulthood.
It is commonly associated with elevated serum immunoglobulin E levels and a personal or family history of allergies, allergic rhinitis and asthma.
It is one of the most common skin diseases afflicting both children and adults.

Atopic%20dermatitis Patient Education

Patient Education

  • Discuss the chronic nature of atopic dermatitis, exacerbating factors and appropriate treatment options
    • Emphasize that atopic dermatitis tends to decrease with increase in age
  • Convey the goal of treatment is control rather than “cure”
  • Discuss that many factors probably contribute to flare-ups and usually a specific cause cannot be found
  • Educate the patient about proper skin care (eg bathing, hydration and use of moisturizers)
    • Patient/caregiver should be instructed to apply emollients liberally 3 minutes after taking a bath 2-3 times daily or frequently as the skin gets dry even in the absence of symptoms
    • Studies showed that correct and adequate instructions for use and application of moisturizers when done properly reduces disease severity and overall topical corticosteroids use
  • Explain potential side effects of medications when used over extended periods of time
    • Apply topical steroid 10-15 minutes after application of emollients
  • Keep fingernails trimmed short
  • Use of cotton gloves at night to limit scratching
Editor's Recommendations
Most Read Articles
Ivermectin improves survival in COVID-19 patients with severe pulmonary involvement
2 days ago
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Mental health problems spell trouble for diabetics
Yesterday
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Empagliflozin not just another SGLT2i: Cardio-renal benefits extend to HF with or without diabetes
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Slight amino acid tweak weakens HBV
Tristan Manalac, 5 days ago
The substitution of isoleucine to leucine at amino acid 97 (I97L) in the core region of the hepatitis B virus (HBV) seems to reduce its potency, decreasing the efficiency of both infection and the synthesis of the virus’ covalently closed circular (ccc) DNA, reports a new study presented at The Liver Meeting Digital Experience by the American Association for the Study of Liver Diseases (AASLD 2020).